Henry Kissinger, Bill Gates, and other luminaries steer a little-known organization that favors exploring a trade pact
The point of a draft is to help the worst teams get better, but the lottery pits the worst teams against the merely mediocre
Startup TrackingPoint sells a rifle with laser and computer technology that lets a novice hit moving targets 500 yards distant—then post the kill online
To extend Internet access throughout the world, Google may be working on balloon-based broadband transmitters
Helped by the Fed, it's very cheap to borrow money. This could end badly
Farmers reported their progress via Twitter and Instagram, using hashtags like #plant13
The film director has a site selling movie-themed T-shirts and memorabilia, as well as promoting a Bolivian liquor
George Washington University is planning a series of undergraduate programs in marketing, international business, and, starting this fall, finance
The West's housing rebound is helping small companies while delinquency rates remain higher along the Eastern seaboard, says a new report
King of Prussia, Pa.
Founders: Dr. Robert Lefkowitz and Dr. Howard Rockman
VC Investment over the last four quarters: $26.1 million
Trevena, founded in January 2008, is a drug discovery company developing pharmaceuticals that target what are known as G-protein coupled receptors. Such drugs make up more than 40% of marketed drugs today, according to Trevena. The company's drug discovery platform is based on research from Duke University Medical Center, including that of founder and National Medal of Science winner Robert Lefkowitz.
Key to startup success: "We've been able to generate the strong investor support for this idea [because] the technology and the opportunity here is very, very unique, and the possibility of unlocking new areas of biology is so significantly different from what's currently out there."